Foundation Medicine
| Company type | Subsidiary |
|---|---|
| Nasdaq: FMI | |
| Headquarters | , United States |
Key people | Daniel Malarek (CEO) |
| Products | FoundationOne CDx FoundationOne Liquid FoundationOne Heme Foundation Insights FoundationSmartTrials |
| Revenue | $152.9 million (2017) |
| Parent | Roche |
| Website | foundationmedicine |
Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.